Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

AstraZeneca Plc made an official statement on Friday, saying that it rejected the increased bid of Pfizer Inc. Pfizer Inc. made an acquisition proposal, which amounted to 63.1 billion pounds (106.5 billion dollars) but was denied because in AstraZeneca’s opinion Pfizer hadnt taken into account the promising perspectives of its drugs under development.

Mr Leif Johansson, who is the Chairman of AstraZeneca, said in the company’s statement, which was cited by Bloomberg: “Pfizer’s proposal would dramatically dilute AstraZeneca shareholders’ exposure to our unique pipeline and would create risks around its delivery. As such, the board has no hesitation in rejecting the proposal.” As reported by the Wall Street Journal, the company also said: “The large proportion of the consideration payable in Pfizer shares and the tax-driven inversion structure remain unchanged. Accordingly, the board has rejected the proposal.”

The British drug maker commented that the financial, as well as other terms of Pfizer’s bid were inadequate. It suggested Pfizers Chief Executive Officer – Mr. Ian Read should raise the company’s offer, negotiate directly with AstraZeneca’s shareholders or withdraw from the deal.

This was the second takeover offer made by Pfizer after its first bid in January 2014. On Friday it raised its offer for an eventual merger with the second-largest drug manufacturer in the U.K. after the Chief Executive Officer of the company had a meeting with AstraZeneca’s shareholders and official representatives of the British government.

However, AstraZeneca may not be supported by the country’s government and the Prime Minister. The government hinted that it does not intend to intervene in the deal and even rejected some political parties’ demands to be more active in protecting jobs in the industry.

As reported by Bloomberg, U.K. Prime Minister Mr. Cameron commented the situation in an interview: “AstraZeneca has a fantastic role in the British economy. Action on any merger is a decision for both companies. We’ve sought and received robust assurances from Pfizer should the deal go ahead.”

AstraZeneca Plc lost 0.15% on Friday to close the session at 4 808 pence per share, marking a one year change of +44.95%. The company is valued at 60.77 billion pounds.

Pfizer Inc. fell by 1.28% to $30.75 per share in New York, marking a one-year change of +5.06%. According to the Financial Times, the 13 analysts offering 12 month price targets for Pfizer Inc. have a median target of $34.00, with a high estimate of $41.00 and a low estimate of $29.00. The median estimate represents a 10.57% increase from the last price of $30.75

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • USD/CAD at session high after Trade Balance data from US and CanadaUSD/CAD at session high after Trade Balance data from US and Canada US dollar rose to session high against the Canadian counterpart on Tuesday, after official data stated that both the US and Canadian trade balance deficits increased during April.USD/CAD reached 1.0336 during early American trade, […]
  • EUR/USD touches one-week lows after Fed taper decisionEUR/USD touches one-week lows after Fed taper decision The euro touched one-week low against the US dollar, after the Federal Reserve Bank announced that it will scale back its monetary stimulus by $10 billion at its two-day policy meeting concluded yesterday.EUR/USD touched a session low at […]
  • Forex Market: USD/CAD daily trading outlookForex Market: USD/CAD daily trading outlook Yesterday’s trade saw USD/CAD within the range of 1.2858-1.3011. The pair closed at 1.2990, edging up 0.09% on a daily basis. It has been the 33rd gain in the past 63 trading days. The daily low has been the lowest level since October 16th […]
  • Forex Market: EUR/GBP daily trading forecastForex Market: EUR/GBP daily trading forecast Yesterday’s trade saw EUR/GBP within the range of 0.7491-0.7564. The daily high has also been the highest level since January 23rd, when a high of 0.7584 was recorded. The pair closed at 0.7546, gaining 0.67% on a daily basis.At 6:58 GMT […]
  • LG Energy Solution to set up $3.1 billion battery plant in Ochang, South KoreaLG Energy Solution to set up $3.1 billion battery plant in Ochang, South Korea LG Energy Solution (373220) on Monday announced plans to invest KRW 4 trillion ($3.1 billion) until 2026 in an EV battery-producing plant in Ochang, South Korea.The project is to include research & development, production […]
  • ThreeD Capital acquires 1,400,000 common shares of Infinitii AIThreeD Capital acquires 1,400,000 common shares of Infinitii AI Canadian venture capital firm ThreeD Capital Inc said on Thursday that it had acquired ownership and control of an aggregate of 1,400,000 common shares of Infinitii AI Inc via a number of transactions ending on December 12th.Those […]